FEASIBILITY, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTFeasibility, Development and Commercialization Agreement • September 9th, 2005 • Voyager Pharmaceutical Corp • Delaware
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MASTER SERVICES AGREEMENTMaster Services Agreement • September 9th, 2005 • Voyager Pharmaceutical Corp • North Carolina
This Master Services Agreement (“Agreement”) is made between Voyager Pharmaceutical Corporation which has a place of business at 8540 Colonnade Center Drive, Suite 409, Raleigh, North Carolina 27615 (hereinafter “Sponsor”), and Quintiles, Inc., a North Carolina corporation having its principal place of business at 5927 South Miami Boulevard, Morrisville, North Carolina 27560 (hereinafter “Quintiles”). When signed by both parties, this Agreement will set forth the terms and conditions under which Quintiles agrees to provide certain services to Sponsor as set forth herein.
Voyager Pharmaceutical Corporation Incentive Stock Option Agreement Granted Under 2005 Stock Incentive PlanIncentive Stock Option Agreement • October 13th, 2005 • Voyager Pharmaceutical Corp • Pharmaceutical preparations
Voyager Pharmaceutical Corporation Nonstatutory Stock Option Agreement Granted Under 2005 Stock Incentive PlanNonstatutory Stock Option Agreement • October 13th, 2005 • Voyager Pharmaceutical Corp • Pharmaceutical preparations
Shares Voyager Pharmaceutical Corporation Common Stock FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2005 • Voyager Pharmaceutical Corp • Pharmaceutical preparations • New York
Voyager Pharmaceutical Corporation, a Delaware corporation (the “Company”) proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional shares (the “Option Shares”) of Common Stock from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively called the “Shares.”
CONSENT TO SUBLEASEConsent to Sublease • September 9th, 2005 • Voyager Pharmaceutical Corp • North Carolina
THIS CONSENT TO SUBLEASE (“Consent”) is made and entered into as of the 30 day of May, 2005 (the “Effective Date”), by and among COLONNADE DEVELOPMENT LLC, a Delaware limited liability company (“Landlord”), SALIX PHARMACEUTICALS, INC., a California corporation (“Tenant”) and VOYAGER PHARMACEUTICAL CORP., a Delaware corporation (“Subtenant”).
CONTRACT FOR SALE AND PURCHASE OF REAL PROPERTYContract for Sale and Purchase of Real Property • September 9th, 2005 • Voyager Pharmaceutical Corp • Florida
This Contract for Sale and Purchase of Real Property (“Agreement”) is executed this 30th day of September, 2004, by Patrick S. Smith and Jane E. Smith (“Seller”) and Voyager Pharmaceutical Corporation, a Delaware corporation (“Buyer”).
LEASE AGREEMENTLease Agreement • September 9th, 2005 • Voyager Pharmaceutical Corp
THIS LEASE AGREEMENT (this “Lease”) is dated as of October 4, 2004, between ARE-7030 KIT CREEK, LLC, a Delaware limited liability company (“Landlord”), and VOYAGER PHARMACEUTICAL, INC., a Delaware corporation (“Tenant”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2005 • Voyager Pharmaceutical Corp • North Carolina
This Employment Agreement (this “AGREEMENT”) is entered into as of February 22, 2005 by and between Voyager Pharmaceutical Corporation, a Delaware corporation (the “COMPANY”), and Sheldon Goldberg, an individual residing at 15835 Delasol Lane, Naples, Florida 34110 (“EXECUTIVE”).
LEASE AGREEMENT By and BetweenLease Agreement • September 9th, 2005 • Voyager Pharmaceutical Corp
